YC S18Acquired
Coral Genomics
New clinical tests for managing autoimmune treatments.
About
Coral integrates molecular, functional, and clinical factors to create new clinical laboratory tests that predict optimal treatments for autoimmune diseases. We have also identified a unique subpopulation of patients who do not respond to current therapies and are working towards addressing this unmet medical need.
Founders
- Atray Dixit
- Jacob Borrajo
Family Office Investors
Altss tracks family office allocations to YC-backed companies. Request access to see which family offices have invested in Coral Genomics.
See family office activityIndustry & Focus
HealthcareDrug Discovery and DeliveryGenomics